Illumina, Inc. (ILMN)
NASDAQ: ILMN · Real-Time Price · USD
94.56
-0.94 (-0.98%)
At close: Aug 8, 2025, 4:00 PM
94.73
+0.17 (0.18%)
After-hours: Aug 8, 2025, 7:44 PM EDT
Apartment Income REIT Market Cap
Illumina has a market cap or net worth of $14.53 billion as of August 8, 2025. Its market cap has decreased by -21.54% in one year.
Market Cap
14.53B
Enterprise Value
15.98B
1-Year Change
-21.54%
Ranking
Category
Stock Price
$94.56
Market Cap Chart
Since July 28, 2000, Illumina's market cap has increased from $1.24B to $14.53B, an increase of 1,076.36%. That is a compound annual growth rate of 10.34%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 8, 2025 | 14.53B | -31.42% |
Dec 31, 2024 | 21.19B | -4.15% |
Dec 29, 2023 | 22.11B | -30.48% |
Dec 30, 2022 | 31.81B | -46.51% |
Dec 31, 2021 | 59.46B | 10.08% |
Dec 31, 2020 | 54.02B | 10.77% |
Dec 31, 2019 | 48.77B | 10.61% |
Dec 31, 2018 | 44.09B | 38.21% |
Dec 29, 2017 | 31.90B | 69.60% |
Dec 30, 2016 | 18.81B | -33.07% |
Dec 31, 2015 | 28.10B | 7.21% |
Dec 31, 2014 | 26.21B | 87.51% |
Dec 31, 2013 | 13.98B | 104.45% |
Dec 31, 2012 | 6.84B | 84.71% |
Dec 30, 2011 | 3.70B | -53.27% |
Dec 31, 2010 | 7.92B | 106.38% |
Dec 31, 2009 | 3.84B | 19.06% |
Dec 31, 2008 | 3.22B | -0.56% |
Dec 31, 2007 | 3.24B | 77.31% |
Dec 29, 2006 | 1.83B | 215.10% |
Dec 30, 2005 | 580.20M | 60.72% |
Dec 31, 2004 | 361.00M | 55.87% |
Dec 31, 2003 | 231.60M | 111.51% |
Dec 31, 2002 | 109.50M | -71.10% |
Dec 31, 2001 | 378.90M | -26.13% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 561.67B |
Johnson & Johnson | 417.44B |
AbbVie | 349.87B |
Abbott Laboratories | 233.71B |
AstraZeneca | 227.85B |
UnitedHealth Group | 227.59B |
Novartis AG | 225.61B |
Novo Nordisk | 224.34B |